Exjade 500 mg, dispergierbare Tabletten
7680574660096
CH-57466
V03AC03
06.99.0.
1 / 3
google
Details
- Product number
- 5746603
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- deferasiroxum 500 mg, crospovidonum, lactosum monohydricum 543.6 mg, cellulosum microcristallinum, povidonum K 30, natrii laurilsulfas, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 0.680 mg.
Articles (1)
Exjade 500 mg, dispergierbare Tabletten
Tabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
543.6 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.68 MG | Substance | HBESI |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 57466
- Drug name
- Exjade, dispergierbare Tabletten
- Galenic form
- TABSU
- ATC Code
- V03AC03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/11/2005
- Authorization expiration date
- 31/12/9999
- IT number
- 06.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EXJADE cpr disp 500 mg 28 pce
- Description (DE)
- EXJADE Disp Tabl 500 mg 28 Stk
- Narcotic (BTM)
- No